Kyntra Bio to Report Second Quarter 2026 Financial Results

Go back to Kyntra Bio to Report Second Quarter 2026 Financial Results
(NASDAQ: KYNB) Delayed: 7.05 +0.01 (0.14%)
Previous Close $7.04    52 Week High
Open $7.03    52 Week Low
Day High $7.41    P/E N/A 
Day Low $6.95    EPS
Volume 17,734